Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr.Ginseng is a South Korean biotechnology company focused on the development of high-potency health functional foods and cosmeceuticals derived from ginseng. The company utilizes a proprietary enzymatic conversion platform to transform standard ginsenosides into rare, highly bioavailable forms such as Compound K and Rg3. By applying pharmaceutical-grade research to traditional herbal medicine, Dr.Ginseng creates products designed to enhance immune function, reduce fatigue, and support cognitive health. Their business model integrates personalized nutrition technology with advanced natural product extraction to provide scientifically validated wellness solutions. The company targets both the domestic Korean market and international consumers seeking premium, research-backed botanical supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr.Ginseng.